New Weight Loss Pill & Massive U.S. Investment Sends Eli Lilly Stock Soaring – Is It Too Late To Buy?
Image Source: Pixabay Eli Lilly (LLY), a pharmaceutical leader in obesity and diabetes treatment, is back in the spotlight, and for good reason. Its experimental weight-loss pill just crushed its Phase 3 trial and the company is doubling down with major …